RE:RE:RE:management fiddles while TST shareprice is burning .........With their third straight reject from the FDA, orphan, Adcomm and now BLA, one would think that they'd get the hint that a backup plan might be necessary. The whole "disappointed" gig whenever the FDA makes a ruling has worn itself out. One of their 50+ employees (now on semi retired light duty) must have clued into this. I'm sure the Type A letter that takes hordes of staff and consulting fees will not result in another "disappointment", in several months.